secwatch.observer — SEC 8-K summary
======================================

Issuer:     UroGen Pharma Ltd. (URGN)
CIK:        0001668243
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001193125-22-280620
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

UroGen Pharma appoints Daniel G. Wildman to board of directors
--------------------------------------------------------------

- Daniel G. Wildman appointed to fill a board vacancy effective November 8, 2022.
- Initial option grant of 20,000 ordinary shares, vesting in equal quarterly installments over 12 quarters.
- Annual retainer of $40,000 for board service plus $5,000 for service on the Compliance Committee.
- Eligible for annual option grant of 10,000 ordinary shares at each annual shareholder meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668243/000119312522280620/0001193125-22-280620-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668243/000119312522280620/d353119d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-280620

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer